| Literature DB >> 35464541 |
Juwairiah Abdur Raheem1, Arshiya Unnisa1, Mohammed Iqubal1.
Abstract
Dapsone, which is used for treating dermatological conditions, can lead to neutropenia. Especially, resistant neutropenia makes patients vulnerable to invasive infections, indicating a medical emergency. Febrile neutropenia secondary to dapsone intake should be treated promptly before the development of sepsis, which may lead to shock and death. In addition, necrotizing fasciitis is a severe and potentially fatal soft-tissue infection that rarely develops in healthy individuals with skin lesions. In this report, we present a case of a patient with no comorbidities who presented with necrotizing fasciitis and neutropenia with a history of dapsone intake.Entities:
Keywords: adult female acne; dapsone; dapsone side effect; necrotizing fasciitis; neutropenic sepsis; organ failure from sepsis; septic shock; severe neutropenia
Year: 2022 PMID: 35464541 PMCID: PMC9001852 DOI: 10.7759/cureus.23076
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Blood test results of the patient
CECT- Contrast-enhanced computed tomography; HRCT- High-resolution computed tomography
| Blood Test | Results |
| C-reactive protein | 12 mg/dl |
| Random blood glucose | >200 mg/dl |
| Arterial blood gas | Compensated metabolic acidosis |
| Complete urine examination | 8-10 pus cells, 5-6 red blood cells, and albuminuria |
| Stool examination | Occult blood positive |
| Coagulation profile | Prothrombin time, 18 seconds; international normal ratio, 1.4 |
| Thyroid-stimulating hormone | 7 uIU/ml |
| Liver function tests | Serum albumin, 2.5 g/dl; alkaline phosphatase, 48 IU/L; alanine transaminase, 68 IU/L; total bilirubin, 5.8 mg/dl (direct, 3 mg/dl; indirect, 2.8 mg/dl) |
| Widal test | Negative |
| Antinuclear antibodies and double-stranded DNA | Negative |
| CECT of the Neck | Cervical lymphadenopathy |
| HRCT of the Chest | Atelectatic changes in the superior segment of the left lower lobe |
Figure 1Fasciotomy performed on the right cheek
Figure 2Leucocyte rate during the hospital stay